BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34591653)

  • 21. PD-1-Expressing SARS-CoV-2-Specific CD8
    Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
    Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report.
    Kongsbak-Wismann M; Al-Jaberi FAH; Schmidt JD; Ghanizada M; Hansen CB; Lopez DV; Woetmann A; Ødum N; Bonefeld CM; Stryhn A; Garred P; Buus S; Geisler C
    Front Immunol; 2021; 12():758154. PubMed ID: 34659264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
    Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
    J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral and lung resident memory T cell responses against SARS-CoV-2.
    Grau-Expósito J; Sánchez-Gaona N; Massana N; Suppi M; Astorga-Gamaza A; Perea D; Rosado J; Falcó A; Kirkegaard C; Torrella A; Planas B; Navarro J; Suanzes P; Álvarez-Sierra D; Ayora A; Sansano I; Esperalba J; Andrés C; Antón A; Ramón Y Cajal S; Almirante B; Pujol-Borrell R; Falcó V; Burgos J; Buzón MJ; Genescà M
    Nat Commun; 2021 May; 12(1):3010. PubMed ID: 34021148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
    Oja AE; Saris A; Ghandour CA; Kragten NAM; Hogema BM; Nossent EJ; Heunks LMA; Cuvalay S; Slot E; Linty F; Swaneveld FH; Vrielink H; Vidarsson G; Rispens T; van der Schoot E; van Lier RAW; Ten Brinke A; Hombrink P
    Eur J Immunol; 2020 Dec; 50(12):1998-2012. PubMed ID: 33073359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis.
    Puzyrenko A; Felix JC; Ledeboer NA; Sun Y; Rui H; Sheinin Y
    Pathology; 2022 Jun; 54(4):404-408. PubMed ID: 34836647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.
    Müller TM; Becker E; Wiendl M; Schulze LL; Voskens C; Völkl S; Kremer AE; Neurath MF; Zundler S
    Front Immunol; 2021; 12():639329. PubMed ID: 33959123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.
    Schwabenland M; Salié H; Tanevski J; Killmer S; Lago MS; Schlaak AE; Mayer L; Matschke J; Püschel K; Fitzek A; Ondruschka B; Mei HE; Boettler T; Neumann-Haefelin C; Hofmann M; Breithaupt A; Genc N; Stadelmann C; Saez-Rodriguez J; Bronsert P; Knobeloch KP; Blank T; Thimme R; Glatzel M; Prinz M; Bengsch B
    Immunity; 2021 Jul; 54(7):1594-1610.e11. PubMed ID: 34174183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
    Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
    Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
    Szabo PA; Dogra P; Gray JI; Wells SB; Connors TJ; Weisberg SP; Krupska I; Matsumoto R; Poon MML; Idzikowski E; Morris SE; Pasin C; Yates AJ; Ku A; Chait M; Davis-Porada J; Guo XV; Zhou J; Steinle M; Mackay S; Saqi A; Baldwin MR; Sims PA; Farber DL
    Immunity; 2021 Apr; 54(4):797-814.e6. PubMed ID: 33765436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
    Notarbartolo S; Ranzani V; Bandera A; Gruarin P; Bevilacqua V; Putignano AR; Gobbini A; Galeota E; Manara C; Bombaci M; Pesce E; Zagato E; Favalli A; Sarnicola ML; Curti S; Crosti M; Martinovic M; Fabbris T; Marini F; Donnici L; Lorenzo M; Mancino M; Ungaro R; Lombardi A; Mangioni D; Muscatello A; Aliberti S; Blasi F; De Feo T; Prati D; Manganaro L; Granucci F; Lanzavecchia A; De Francesco R; Gori A; Grifantini R; Abrignani S
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34376481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.